Ginkgo Bioworks’ (NYSE:DNA) first quarter results were something of a mixed bag, with continued progression on a number of metrics offset by rising costs...
By Ian Walker Surgical Innovations Group said Monday that it has appointed Jonathan Glenn as chairman from September, replacing Nigel Rogers. The London-listed provider...
Hello and welcome to Financial Face-off, a MarketWatch column where we help you weigh a financial decision. Our columnist will give her verdict. Tell...
By Raghav Mahobe (Reuters) -Ironwood Pharmaceuticals Inc said on Monday it would buy Switzerland-based drug developer VectivBio Holding AG for $1.15 billion, adding a...
Three companies dominate Canada’s midstream energy business. In contrast, ownership of oil and gas pipelines, gathering and processing systems, storage and other related infrastructure...